Several private sector partners have made new funding commitments to providing childhood immunizations for developing countries, Gavi, the Vaccine Alliance, said Monday.
The commitments came at the Gavi Pledging Conference in Berlin, which was under German Chancellor Angela Merkel’s patronage.
Gavi estimates that industry support will provide $7.5 billion U.S. to fund Gavi’s goal to immunize 300 million children in the world’s poorest countries from 2016 to 2020. Such actions would save 5 million to 6 million lives.
The commitments will enable developing countries to purchase vaccines at a significantly lower cost. Some commitments pertain to further supporting developing countries as they gain the ability to sustain themselves.
Individuals and companies making commitments include GSK, Biological E, Janssen, Panacea Biotech, Pfizer, Sanofi Pasteur and the Serum Institute of India.
In addition, the Alwaleed Bin Talal Foundation (Saudi Arabia), Comic Relief (UK), the IKEA Foundation and UPS have created new partnerships with Gavi. Each partnership brings its own area of expertise to benefit the cause; UPS, for example, will use its global logistics to improve Gavi’s supply chains.
Newlink Genetics and Merck also committed to provide developing countries with their investigational Ebola vaccine at as reduce a price as possible.
Additionally, the International Federation of Pharmaceutical Wholesalers, the World Economic Forum, Star Syringe and Hindustan Syringes and Medical Devices also made commitments to assist Gavi.
Gavi also received pledges from its pre-existing private sector partners LDS Charities, “La Caixa” Foundation, the Lions Clubs International Foundation and matches thanks to the Gavi Matching Fund.
The conference resulted in approximately $95 million U.S. being raised. This sum includes $18.2 million of in-kind contributions. The figure will be the basis of Gavi’s plans for 2015.
“Gavi’s private sector partners play a key role in bringing new ideas and expertise to support our mission,” Gavi CEO Seth Berkley said. “By bringing the best of the private sector to Gavi, together we are able to find innovative ways to solve the big challenges of immunization, such as improving supply chains, and ensure that more children can be reached with vaccines.”